Theracal Pulpotomy in Primary Molars
- Conditions
- Deep Caries
- Interventions
- Drug: FormocresolDrug: Theracal LC
- Registration Number
- NCT04397094
- Lead Sponsor
- Ain Shams University
- Brief Summary
Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.
- Detailed Description
sixty primary molars were either treated with Theracal LC or formocresol pulpotomy. Teeth were followed up clinicaly and radiographically for 12 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- healthy, cooperative children
- mandibular primary molars with vital pulp exposures
- clinical or radiographic evidence of irreversible pulpitis
- physiological root resorption
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Formocresol Formocresol Formocresol was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months. Theracal LC Theracal LC Theracal LC was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.
- Primary Outcome Measures
Name Time Method Clinical Examination 12 months Number of participants with tooth mobility, restoration loss, gingival swelling/fistula, pain on percussion.
- Secondary Outcome Measures
Name Time Method Radiographic Examination 12 months Number of participants showing teeth with inter-radicular bone resorption, periapical bone resorption, internal root resorption, external root resorption, widening of periodontal ligament space.
Trial Locations
- Locations (1)
Faculty of Dentistry, Ain Shams University
🇪🇬Cairo, Egypt